Ildong Pharmaceutical Co., Ltd. (KRX: 249420)

Ildong Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	48,861	53,258	52,146	135,586	85,564	89,959
Short-Term Investments	12,560	28,021	16,600	19,095	600	600
Trading Asset Securities	-	-	10,000	-	-	-
Cash & Short-Term Investments	61,421	81,279	78,746	154,681	86,164	90,559
Cash Growth	-3.38%	3.22%	-49.09%	79.52%	-4.85%	16.65%
Accounts Receivable	54,538	56,245	53,916	51,818	49,517	63,643
Other Receivables	5,232	2,735	4,158	3,026	1,241	2,832
Receivables	66,631	62,650	58,074	54,844	50,758	66,979
Inventory	88,262	84,623	98,249	82,587	89,227	69,744
Prepaid Expenses	3,415	1,623	1,270	1,363	1,408	1,627
Other Current Assets	8,421	5,506	45,697	7,008	5,686	4,457
Total Current Assets	228,150	235,681	282,035	300,485	233,243	233,367
Property, Plant & Equipment	225,651	256,380	255,317	247,790	256,419	259,521
Long-Term Investments	19,952	18,996	21,395	22,432	21,675	11,584
Goodwill	5,527	5,527	5,527	5,527	-	-
Other Intangible Assets	24,909	30,079	31,401	38,926	38,283	39,653
Long-Term Accounts Receivable	311.05	442.14	542.83	-	-	-
Long-Term Deferred Tax Assets	46,702	53,888	43,822	66,016	24,935	32,263
Long-Term Deferred Charges	6,228	6,505	10,193	22,174	24,788	29,955
Other Long-Term Assets	30,827	1,689	3,630	3,808	4,213	4,463
Total Assets	590,461	611,261	655,810	708,970	605,277	612,723
Accounts Payable	47,280	50,250	46,099	38,334	35,988	39,764
Accrued Expenses	35,385	33,277	33,734	34,930	20,804	27,002
Short-Term Debt	112,345	164,672	140,743	88,400	65,400	74,400
Current Portion of Long-Term Debt	3,136	13,000	1,000	42,000	23,000	33,000
Current Portion of Leases	4,195	3,575	6,618	4,035	3,956	3,336
Current Income Taxes Payable	672.15	68.3	268.05	7.55	129.16	1,389
Current Unearned Revenue	-	-	-	600	-	-
Other Current Liabilities	76,015	44,273	82,182	149,456	35,733	32,951
Total Current Liabilities	279,028	309,115	310,644	357,763	185,010	211,843
Long-Term Debt	56,649	14,825	16,000	60,404	42,000	23,000
Long-Term Leases	18,576	16,654	43,387	31,316	32,500	32,185
Long-Term Deferred Tax Liabilities	1.43	1.43	6.06	-	-	-
Other Long-Term Liabilities	11,631	29,099	9,688	10,375	10,328	10,110
Total Liabilities	427,914	431,880	451,940	542,008	350,730	359,831
Common Stock	28,063	28,063	26,803	23,803	23,803	22,670
Additional Paid-In Capital	173,327	173,359	377,287	210,262	209,614	238,947
Retained Earnings	-70,507	-58,540	-211,102	-81,951	14,856	-4,872
Treasury Stock	-2,307	-2,307	-365.05	-365.05	-365.05	-321.71
Comprehensive Income & Other	28,331	28,968	-1,379	1,159	6,640	-3,532
Total Common Equity	156,905	169,543	191,244	152,909	254,547	252,892
Minority Interest	527.01	4,723	6,981	7,676	-	-
Shareholders' Equity	162,547	179,381	203,870	166,962	254,547	252,892
Total Liabilities & Equity	590,461	611,261	655,810	708,970	605,277	612,723
Total Debt	194,901	212,726	207,748	226,155	166,856	165,922
Net Cash (Debt)	-133,480	-131,447	-129,002	-71,474	-80,692	-75,362
Net Cash Per Share	-4790.82	-4862.98	-4896.88	-3004.97	-3392.40	-3167.75
Filing Date Shares Outstanding	27.93	27.93	26.79	23.79	23.79	22.66
Total Common Shares Outstanding	27.93	27.93	26.79	23.79	23.79	23.79
Working Capital	-50,878	-73,434	-28,609	-57,279	48,233	21,525
Book Value Per Share	5617.33	6069.76	7139.87	6428.69	10701.87	10630.38
Tangible Book Value	126,469	133,936	154,315	108,456	216,264	213,238
Tangible Book Value Per Share	4527.70	4795.03	5761.20	4559.77	9092.34	8963.54
Land	50,391	72,561	35,125	35,125	35,125	35,125
Buildings	82,451	141,614	140,941	140,732	138,731	137,300
Machinery	64,716	211,982	206,257	195,601	185,845	174,805
Construction In Progress	8,465	3,694	1,963	3,683	5,988	6,204

Source: S&P Capital IQ. Standard template. Financial Sources.